- Researchers reported on a global survey of ophthalmology clinics on managing diabetic macular edema (DME)
- They identified challenges to patient adherence: transportation difficulties, emotional and financial strain, knowledge gaps about DME
- Potential solutions included longer-acting anti-VEGF agents and improved patient-provider discussions
- The researchers also recommended gigital health tools and financial assistance programs to improve disease awareness and self-management
- Limitations included possible bias from self-reported data and communication limitations during COVID-19
Source: Ophthalmology and Therapy